Clinical trial
A Prospective, 5-Year Global Study on MAST™ Minimally Invasive Fusion Procedures for the Treatment of the Degenerative Lumbar Spine
NCT02617563 is registered in ClinicalTrials.gov with Medtronic Spinal and Biologics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, 5-Year Global Study on MAST™ Minimally Invasive Fusion Procedures for the Treatment of the Degenerative Lumbar Spine
- Lead sponsor
- Medtronic Spinal and Biologics
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 31, 2015
- Completion date
- November 14, 2024
- Enrollment
- 361 (actual)
- Sites
- 27
Conditions
As the registry lists them; a condition with its own page is linked.